Treatment with docetaxel in combination with Aneustat leads to potent inhibition of metastasis in a patient-derived xenograft model of advanced prostate cancer
Treatment with docetaxel in combination with Aneustat leads to potent inhibition of metastasis in a patient-derived xenograft model of advanced prostate cancer, Published online: 30 January 2018; doi:10.1038/bjc.2017.474
Treatment with docetaxel in combination with Aneustat leads to potent inhibition of metastasis in a patient-derived xenograft model of advanced prostate cancerhttp://ift.tt/2noY6eO
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου